spacer
home > subscribe
SUBSCRIPTION FORM

Our magazines are available free of charge on a controlled basis to senior level management within the pharmaceutical industry. Click on the following links for the relevant subscription form. Alternatively, if you do not qualify for a free subscription, please complete the below.

European Biopharmaceutical Review

European Pharmaceutical Contractor 

International Clinical Trials 

Innovations in Pharmaceutical Technology 

Pharmaceutical Manufacturing and Packing Sourcer

If you do not meet our qualification criteria, please fill in the form below for a paid subscription. The annual subscription price for one title is 145. 

Cheques should be made payable to Samedan Ltd, First Floor, 131 Edgware Road, London, W2 2HR, UK. Credit card details can be given over the telephone - please ask for the Accounts Department. Back issues of the publications are available. For further details, please contact our Circulation Department on +44 (0)20 7724 3456.

Title: First Name: Last Name:
Address 1:
Address 2:
Town / City: ZIP / Post Code:
Country: Other:
Tel.: E-mail:
Subscribe to:ICTEPCEBRPMPSIPT
Additional Information:
Payment Method:
online   cheque/postal ordrer  
spacer
News and Press Releases

Clinical and Regulatory Operational Excellence Forum

1. Innovative technologies are expected to take clinical development, licensing, and other regulatory processes to the next level in the future. What do you see are the biggest challenges facing companies when trying to cope with continued data growth in a fast changing environment? Pharmaceutical companies are heavily regulated and introducing change needs proof of acceptance by the authorities. The chance that authorities do not agree with that change makes the industry risk averse. Changes in a stable GxP environment are almost by default seen as a risk, however, not adapting to new technologies should also be seen as a risk! Therefore, ICH developed the ICH Q8, Q9, Q10, Q11, and Q12 guidelines, to anticipate change and implement changes much faster, with less of a regulatory burden. Nevertheless, industry is not picking up with the desired pace. Why not?
More info >>

.
White Papers

Clinical Trials in Russia Orange Paper: Summary of Year 2013

Synergy Research Group

Russia remains a very popular geography for local, regional, and global pharmaceutical companies to conduct clinical trials. Sponsors mention the following reasons for conducting studies in Russia: 1. Fast patient enrollment due to the centralized medical infrastructure. 2. Nearly 100% patient retention 3. GCP trained and certified Investigative Sites generating high quality data 4. Low cost: Average per patient cost is 60% to 70% below US and European prices due to the low cost of Investigators and the high concentration of patients in therapeutically aligned medical centers
More info >>

 
Industry Events

ASGCT 22nd Annual Meeting

29 April - 2 May 2019, Washington Hilton, Washington, D.C

The 2019 ASGCT Annual Meeting is expected to be the largest in Society history, eclipsing the mark set by the 2018 meeting just last year. Join more than 3,500 researchers, clinicians, advocates, and industry leaders in discovering the latest science and technology surrounding gene and cell therapy.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement